Close

Now Playing: India Novartis patent ruling: Good for access, bad for innovation?

India's Supreme Court has rejected a patent filed by Swiss drug maker Novartis for its cancer drug. The decision has implications for the pharmaceutical industry and millions of people in poor countries.